Home|
A Regeneron Drug Minimized Recurrence of Gout in Clinical Trial Results about the promising gout treatment Arcalyst come from a midstage trial involving a limited number of patients, but a larger study is planned for next year. Home > Rss Directory > Business > NY Time |
|
Clinical Trial Touches Off Drug Access Fight A family says a drug company led them to believe that their 16-year-old son could participate in a clinical trial for an experimental muscular dystrophy drug, but then went back on its word. Home > Rss Directory > Business > NY Time |
|
Anti-HIV Drug Trial Produces Mixed Results - MedHeadlines KCBY.com 11Anti-HIV Drug Trial Produces Mixed ResultsMedHeadlines - 2 hours agoBy MedHeadlines • Feb 18th, 2008 • Category: AIDS, Drugs, HIV, Medical Research The Population Council announced from both New York City and Johannesburg, South Africa, recently Home > Rss Directory > General > Google News |
|
Revealing What Drug Companies Wouldn't Tell You - ABC News NY1Revealing What Drug Companies Wouldn't Tell YouABC News - 3 hours agoResults of a clinical trial found that the cholesterol drug Vytorin did not reduce harmful plaque buildup in arteries any better than a cheaper generic drug did, but drugmakers withheld that inform Home > Rss Directory > General > Google News |
|
MS Drug Clinical Trial Doesn't Excite Human Genome Stockholders (AHN) (AHN) - News of a potentially exciting MS drug trial failed to cause HGS shares to recover from January's Albuferon warning. - Thu, 29 May 2008 10:24:39 GMT (AHN) Home > Rss Directory > Business > AllHeadline |
|
Study Reveals Doubt on Drug for Cholesterol A clinical trial of Zetia, a widely used cholesterol drug, has raised questions about its effectiveness and the behavior of pharmaceutical companies that conducted the study. Home > Rss Directory > Business > NY Time |
|
Amgen Posts Weak Results, but Hails Osteoporosis Drug The biotechnology company said Thursday that its experimental osteoporosis drug proved superior to Fosamax from Merck in a clinical trial. Home > Rss Directory > Business > NY Time |
|
Drug Fails to Slow Nerve Damage Genentech and Biogen Idec’s cancer drug Rituxan did not slow the disabling effects of the most difficult form of multiple sclerosis in a large clinical trial. Home > Rss Directory > Business > NY Time |
|
Myriad Genetics Stops Work on Alzheimer’s Drug Flurizan, a drug developed by Myriad Genetics to treat Alzheimer’s disease, failed in a closely watched late-stage clinical trial, dealing another blow to efforts to combat the illness. Home > Rss Directory > Business > NY Time |
|
Wyeth and Elan Shares Plunge on Alzheimer’s Drug Results Detailed clinical trial results for the companies’ new Alzheimer’s drug raised safety issues and disappointed bullish investors. Home > Rss Directory > Business > NY Time |
|
Signs That Diabetes Drug May Extend Lives Byetta, an injectable drug that lowers blood sugar, may help people with diabetes to live longer, according to the results of a major clinical trial. Home > Rss Directory > Business > NY Time |
|
Lilly Diabetes Drug Shows a Life-Extending Promise Byetta, an injectable drug that lowers blood sugar, may help people with diabetes to live longer, according to the results of a major clinical trial. Home > Rss Directory > Business > NY Time |
|
F.D.A. Delays Clinical Trial of Embryonic Stem Cells The Geron Corporation announced Wednesday that its plans to begin the first clinical trial using embryonic stem cells had been delayed by federal regulators. Home > Rss Directory > Business > NY Time |
|
Gout surge blamed on sweet drinks Sugary soft drinks and fruit juices increase the risk of gout in men, a study claims. Home > Rss Directory > General > BBC |
|
Narcolepsy drug helps cancer-related fatigue: study - Reuters Canada.comNarcolepsy drug helps cancer-related fatigue: studyReuters - 1 hour agoCHICAGO (Reuters) - The narcolepsy drug Provigil can alleviate severe cancer-related fatigue, according to new research presented on Saturday at a meeting of the American Society for Clinic Home > Rss Directory > General > Google News |
|
For Widely Used Drug, Question of Usefulness Is Still Lingering - New York Times Canada.comFor Widely Used Drug, Question of Usefulness Is Still LingeringNew York Times - 2 hours agoBy ALEX BERENSON When the Food and Drug Administration approved a new type of cholesterol-lowering medicine in 2002, it did so on the basis of a handful of clinical tri Home > Rss Directory > General > Google News |
|
Resveratrol-like drug works in humans-Sirtris - Reuters Resveratrol-like drug works in humans-SirtrisReuters - 2 hours agoBy Julie Steenhuysen CHICAGO (Reuters) - A drug that exploits the benefits of a component in wine proved safe and showed signs that it might improve blood sugar control in people with the most common form of Home > Rss Directory > General > Google News |
|
Drug Has No Benefit in Trial, Makers Say The outcome of a trial that failed to show that Zetia has any medical benefits adds to concerns over the drug. Home > Rss Directory > General > NY Time |
|
Accused Afghan drug lord goes on trial in New York
(Reuters) Reuters - An accused Afghan heroin kingpin went on trial on Tuesday in a case that his lawyers said will show how the United States once cooperated with and then turned against an international drug smuggler. Home > Rss Directory > General > Yahoo News |
|
Wyeth, Elan Alzheimer's Drug Has Side Effects, Limits (Update1) - Bloomberg Wall Street Journal BlogsWyeth, Elan Alzheimer's Drug Has Side Effects, Limits (Update1)Bloomberg - 22 minutes agoBy Tom Randall and Elizabeth Lopatto July 29 (Bloomberg) -- An experimental Alzheimer's drug made by Wyeth and Elan Corp. only helped about half of patients Home > Rss Directory > General > Google News |